Intramyocardial autologous bone marrow cell transplantation for ischemic heart disease: A systematic review and meta-analysis of randomized controlled trials

Atherosclerosis

Volumn 233, Issue 2, 2014, Pages 485-492

  Tian, Tao ^a   Chen, Bingwei ^a   Xiao, Yan ^a   Yang, Kunqi ^a   Zhou, Xianliang ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Bone marrow cells; Heart failure; Meta analysis; Myocardial ischemia; Stem cells

Indexed keywords

AUTOLOGOUS BONE MARROW TRANSPLANTATION; CEREBROVASCULAR DISEASE; CLINICAL EFFECTIVENESS; CORONARY ARTERY BYPASS GRAFT; ECHOCARDIOGRAPHY; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; INTRAMYOCARDIAL AUTOLOGOUS BONE MARROW CELL TRANSPLANTATION; ISCHEMIC HEART DISEASE; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMATIC REVIEW; AUTOTRANSPLANTATION; BIOLOGICAL MODEL; BONE MARROW TRANSPLANTATION; COMPLICATION; ETIOLOGY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; INJECTION; METHODOLOGY; MYOCARDIAL ISCHEMIA; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; PUBLISHING; STATISTICS AND NUMERICAL DATA; SURGERY; TREATMENT OUTCOME;

BONE MARROW TRANSPLANTATION; CORONARY ARTERY BYPASS; HUMANS; INJECTIONS; MODELS, CARDIOVASCULAR; MYOCARDIAL ISCHEMIA; MYOCARDIUM; POSTOPERATIVE COMPLICATIONS; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; STROKE VOLUME; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84896265029     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.01.027     Document Type: Review

References (41)

1. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125:e2-e220.
2. Dai W., Kloner R.A. Bone marrow-derived cell transplantation therapy for myocardial infarction: lessons learned and future questions. Am J Transplant 2011, 11:2297-2301.
3. Strauer B.E., Brehm M., Zeus T., et al. Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction. Dtsch Med Wochenschr 2001, 126:932-938.
4. Schachinger V., Erbs S., Elsasser A., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. NEngl J Med 2006, 355:1210-1221.
5. Cao F., Sun D., Li C., et al. Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up. Eur Heart J 2009, 30:1986-1994.
6. Lipinski M.J., Biondi-Zoccai G.G., Abbate A., et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. JAm Coll Cardiol 2007, 50:1761-1767.
7. Delewi R., Andriessen A., Tijssen J.G., et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a meta-analysis of randomised controlled clinical trials. Heart 2013, 99:225-232.
8. Patel A.N., Geffner L., Vina R.F., et al. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. JThorac Cardiovasc Surg 2005, 130:1631-1638.
9. Tse H.F., Thambar S., Kwong Y.L., et al. Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial). Eur Heart J 2007, 28:2998-3005.
10. Hendrikx M., Hensen K., Clijsters C., et al. Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial. Circulation 2006, 114:I101-I107.
11. Perin E.C., Silva G.V., Henry T.D., et al. Arandomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell functionanalysis in ischemic heart failure (FOCUS-HF). Am Heart J 2011, 161:1078-1087. e3.
12. Moher D., Liberati A., Tetzlaff J., et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009, 339:b2535.
13. Bellenger N.G., Burgess M.I., Ray S.G., et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable?. Eur Heart J 2000, 21:1387-1396.
14. Juni P., Altman D.G., Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001, 323:42-46.
15. Ang K.L., Chin D., Leyva F., et al. Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone. Nat Clin Pract Cardiovasc Med 2008, 5:663-670.
16. + bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. JThorac Cardiovasc Surg 2007, 133:717-725.
17. Zhao Q., Sun Y., Xia L., et al. Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery. Ann Thorac Surg 2008, 86:1833-1840.
18. Perin E.C., Willerson J.T., Pepine C.J., et al. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA 2012, 307:1717-1726.
19. Perin E.C., Silva G.V., Zheng Y., et al. Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure. Am Heart J 2012, 163:415-421. 21 e1.
20. Pokushalov E., Romanov A., Chernyavsky A., et al. Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study. JCardiovasc Transl Res 2010, 3:160-168.
21. van Ramshorst J., Bax J.J., Beeres S.L., et al. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. JAMA 2009, 301:1997-2004.
22. Donndorf P., Kundt G., Kaminski A., et al. Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-analysis. JThorac Cardiovasc Surg 2011, 142:911-920.
23. Cheng K., Wu F., Cao F. Intramyocardial autologous cell engraftment in patients with ischaemic heart failure: a meta-analysis of randomised controlled trials. Heart Lung Circ 2013, 22:887-894.
24. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701-705.
25. Balsam L.B., Wagers A.J., Christensen J.L., et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004, 428:668-673.
26. Murry C.E., Soonpaa M.H., Reinecke H., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004, 428:664-668.
27. Weil B.R., Canty J.M. Stem cell stimulation of endogenous myocyte regeneration. Clin Sci (Lond) 2013, 125:109-119.
28. Hansson E.M., Lendahl U. Regenerative medicine for the treatment of heart disease. JIntern Med 2013, 273:235-245.
29. Hatzistergos K.E., Quevedo H., Oskouei B.N., et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 2010, 107:913-922.
30. Loffredo F.S., Steinhauser M.L., Gannon J., Lee R.T. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 2011, 8:389-398.
31. + bone marrow progenitor cells and improve regional function in hibernating myocardium. Circ Res 2011, 109:1044-1054.
32. Tse H.F., Siu C.W., Zhu S.G., et al. Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium. Eur J Heart Fail 2007, 9:747-753.
33. Dai Y., Ashraf M., Zuo S., et al. Mobilized bone marrow progenitor cells serve as donors of cytoprotective genes for cardiac repair. JMol Cell Cardiol 2008, 44:607-617.
34. Burchfield J.S., Iwasaki M., Koyanagi M., et al. Interleukin-10 from transplanted bone marrow mononuclear cells contributes to cardiac protection after myocardial infarction. Circ Res 2008, 103:203-211.
35. Perin E.C., Silva G.V., Assad J.A., et al. Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. JMol Cell Cardiol 2008, 44:486-495.
36. George J.C., Goldberg J., Joseph M., et al. Transvenous intramyocardial cellular delivery increases retention in comparison to intracoronary delivery in a porcine model of acute myocardial infarction. JInterv Cardiol 2008, 21:424-431.
37. Brunskill S.J., Hyde C.J., Doree C.J., et al. Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease. Eur J Heart Fail 2009, 11:887-896.
38. Kandala J., Upadhyay G.A., Pokushalov E., et al. Meta-analysis of stem cell therapy in chronic ischemic cardiomyopathy. Am J Cardiol 2013, 112:217-225.
39. Galinanes M., Loubani M., Davies J., et al. Autotransplantation of unmanipulated bone marrow into scarred myocardium is safe and enhances cardiac function in humans. Cell Transplant 2004, 13:7-13.
40. Hu X., Yu S.P., Fraser J.L., et al. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. JThorac Cardiovasc Surg 2008, 135:799-808.
41. Saini U., Gumina R.J., Wolfe B., et al. Preconditioning mesenchymal stem cells with caspase inhibition and hyperoxia prior to hypoxia exposure increases cell proliferation. JCell Biochem 2013, 114:2612-2623.